Plain Language Summary of the FOENIX-CCA2 Study: Futibatinib for People with Advanced Bile Duct Cancer.
Lipika Goyal,Funda Meric-Bernstam,Antoine Hollebecque,Juan W. Valle,Chigusa Morizane,Thomas B. Karasic,Thomas A. Abrams,Junji Furuse,Robin Katie Kelley,Philippe A. Cassier,Heinz-Josef Klumpen,Heung-Moon Chang,Li-Tzong Chen,Josep Tabernero,Do-Youn Oh,Amit Mahipal,Markus Moehler,Yoshito Komatsu,Daniel H. Ahn,Robert S. Epstein,Abdel-Baset Halim,Volker Wacheck,Yaohua He, Mei Liu,Karim A. Benhadji,John A. Bridgewater FUTURE ONCOLOGY（2024）
关键词
Cholangiocarcinoma,futibatinib,phase 2
AI 理解论文
溯源树
样例
